Aktienanalyse zu Integer Holdings Corp (ITGR)ITGRInteger Holdings Corp

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is currently not a strong buy due to its recent downgrades and market uncertainties. The stock is trading at $126.54, just below the acquisition price of $127, indicating limited upside potential. The RSI is at 37.997, suggesting it is nearing oversold territory, but the lack of a clear growth outlook and the withdrawal of guidance due to the acquisition creates uncertainty. The main risk is the projected sales growth slowing to 1.6% over the next 12 months, which could impact profitability.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.